“A GREAT OFFICE FOR LICENSING“ IAM MAGAZINE 2016
Yuval Horn, Ohad Mamann and Anat Polyachenko of Horn & Co. represented the shareholders of Famewave Ltd. in the acquisition of Famewave by Kitov Pharmaceuticals Ltd. (NASDAQ/TASE: KTOV) in consideration for $10 million and a simultaneous investment of $3.5 million by certain shareholders in Kitov. Famewave Ltd. was set up by the former shareholders of cCAM Biotherapeutics Ltd., which we represented in the acquisition by MSD in 2015.
Horn & Co. once again recognized as one of the elite law firms in Israel by Dun & Bradstreet, in its 2018 ranking by fields of expertise.
Yuval Horn will co-chair the 4th Annual Mergers and Acquisitions in the Technology Sector Conference of the International Bar Association, to take place on March 28-29, 2019 in Barcelona.